Grupp, S. A., Maude, S. L., Rives, S., Baruchel, A., Boyer, M., Bittencourt, H., … Hiramatsu, H. (2019). Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 25).

Grupp, Stephan A., Shannon L. Maude, Susana Rives, Andre Baruchel, Michael Boyer, Henrique Bittencourt, Peter Bader, et al. “Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Vol. 25, 2019.

Grupp SA, Maude SL, Rives S, Baruchel A, Boyer M, Bittencourt H, et al. Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2019.

Grupp, Stephan A., et al. “Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 25, no. 3, 2019.

Grupp SA, Maude SL, Rives S, Baruchel A, Boyer M, Bittencourt H, Bader P, Buchner J, Laetsch TW, Stefanski H, Myers GD, Qayed M, Pulsipher MA, De Moerloose B, Yanik GA, Davis KL, Martin PL, Nemecek ER, Peters C, Krueger J, Balduzzi AS, Boissel N, Mechinaud F, Leung M, Eldjerou L, Bleickardt E, Mueller KT, Hiramatsu H. Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2019.